RHY 10.0% 7.7¢ rhythm biosciences limited

Why isn't Colostat being sold into European markets and NZ?, page-11

  1. 280 Posts.
    lightbulb Created with Sketch. 95
    I believe they will require a partnership, as per my previous post, Trevor Lockett was suggesting this back in 2018. It would be a fantastic market entry opportunity if they strike the right deal/s with an established pharmaceutical company.
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.